Skip to main content

Enanta Pharmaceuticals Inc

ENTA
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001177648

No open-market purchases or sales by Enanta Pharmaceuticals Inc insiders were filed in the last 90 days; 122 institutions reported holding it in 13F filings for Q2 2026, worth $397.2M in total; no superinvestor holds it.

Q2 2021 vs. Q1 2021

How the institutions holding Enanta Pharmaceuticals Inc changed between Q1 2021 and Q2 2021.

All holders in Q2 2021All holders in Q1 2021

13F holders of ENTA: Q1 2021 compared with Q2 2021
MeasureQ1 2021Q2 2021Change
Holders150152+2
Shares19.4M18.8M−605.1K (−3.1%)
Value$956.7M$828.7M−$128.1M (−13.4%)

New holders (18)

Institutions that held Enanta Pharmaceuticals Inc at the end of Q2 2021 but not at the end of Q1 2021.

Institutions new to ENTA in Q2 2021
InstitutionSharesValue% of portfolio
State of New Jersey Common Pension Fund D51,583$2.27M0.01%
International Biotechnology Trust PLC34,047$1.50M0.40%
First Manhattan Co33,200$1.46M0.01%
Assenagon Asset Management S.A.16,357$720.0K0.00%
HRT Financial LP15,830$696.0K0.01%
M&G Investment Management Ltd15,432$679.0K0.00%
HSBC Holdings PLC11,906$529.0K0.00%
Public Employees Retirement Association of Colorado11,982$527.0K0.00%
Amalgamated Bank9,153$403.0K0.00%
Jane Street Group, LLC9,060$399.0K0.00%
Jump Financial, LLC8,400$370.0K0.04%
Trexquant Investment LP7,958$350.0K0.03%
Gsa Capital Partners LLP6,281$276.0K0.03%
Handelsbanken Fonder AB5,500$242.0K0.00%
Squarepoint Ops LLC4,924$217.0K0.00%
Sageworth Trust Co90$4.00K0.00%
TCI Wealth Advisors, Inc.41$2.00K0.00%
FMR LLC12$1.00K0.00%

Sold out (16)

Institutions that held Enanta Pharmaceuticals Inc at the end of Q1 2021 and filed for Q2 2021 without it.